Compare FRMM & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FRMM | HYFT |
|---|---|---|
| Founded | N/A | 1983 |
| Country | United States | United States |
| Employees | 2 | 102 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 65.8M | 71.9M |
| IPO Year | 2017 | N/A |
| Metric | FRMM | HYFT |
|---|---|---|
| Price | $5.10 | $1.53 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $5.00 | $5.00 |
| AVG Volume (30 Days) | 296.3K | ★ 583.4K |
| Earning Date | 05-26-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $183.55 | N/A |
| Revenue Next Year | $166.48 | $29.18 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.76 | $0.99 |
| 52 Week High | $5.87 | $3.00 |
| Indicator | FRMM | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 55.08 | 48.64 |
| Support Level | $3.61 | $1.09 |
| Resistance Level | $5.37 | $1.96 |
| Average True Range (ATR) | 0.44 | 0.16 |
| MACD | -0.01 | -0.04 |
| Stochastic Oscillator | 52.81 | 10.68 |
Forum Markets Inc is a financial technology company focused on developing infrastructure that supports the origination, financing, and distribution of RWAs through blockchain-enabled capital markets. The company's business approach is centered on integrating traditional financial asset markets with blockchain-based infrastructure to enable the tokenization of income-generating real-world assets such as consumer credit, equipment finance assets, and other contractual cash-flow streams. It utilizes blockchain infrastructure, including Ethereum and related Layer-2 scaling protocols, to support the issuance, management, and potential secondary trading of tokenized financial instruments.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.